Arcus Historical Cash Flow
| RCUS Stock | USD 17.42 0.05 0.29% |
Analysis of Arcus Biosciences cash flow over time is an excellent tool to project Arcus Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 7.6 M or Depreciation of 4.6 M as it is a great indicator of Arcus Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Arcus Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arcus Biosciences is a good buy for the upcoming year.
Arcus |
About Arcus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Arcus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Arcus's non-liquid assets can be easily converted into cash.
Arcus Biosciences Cash Flow Chart
Add Fundamental
Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Arcus Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Arcus Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.At this time, Arcus Biosciences' Sale Purchase Of Stock is comparatively stable compared to the past year. Investments is likely to gain to about 223.7 M in 2024, despite the fact that Free Cash Flow is likely to grow to (313.5 M).
Arcus Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Arcus Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arcus Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 107.8M | 125.0M | (94K) | (54K) | (6K) | 0.0 | |
| Investments | 61.1M | (431.3M) | (28.8M) | (413M) | 213M | 223.7M | |
| Change In Cash | (13.1M) | 115.5M | (22.7M) | 58M | (79M) | (75.1M) | |
| Stock Based Compensation | 9.0M | 22M | 55M | 65M | 73M | 76.7M | |
| Free Cash Flow | (75.4M) | 108.1M | (282.2M) | 426M | (330M) | (313.5M) | |
| Change In Working Capital | 125K | 208.1M | (375.6M) | 623M | (71M) | (67.5M) | |
| Begin Period Cash Flow | 71.3M | 58.1M | 173.6M | 151M | 209M | 120.1M | |
| Total Cashflows From Investing Activities | 59.2M | (434.4M) | (3.9M) | (413M) | (371.7M) | (353.1M) | |
| Other Cashflows From Financing Activities | 1.2M | 4.7M | 12.3M | 33M | 8M | 7.6M | |
| Depreciation | 3.6M | 4.2M | 3.8M | 6M | 8M | 4.6M | |
| Other Non Cash Items | (1.4M) | (46K) | 3.5M | 11M | (9M) | (8.6M) | |
| Capital Expenditures | 1.9M | 3.1M | 26.1M | 12M | 24M | 25.2M | |
| Total Cash From Operating Activities | (73.5M) | 111.2M | (256.2M) | 438M | (306M) | (290.7M) | |
| Change To Operating Activities | 531K | 21.3M | 14.1M | 23M | 26.5M | 27.8M | |
| Net Income | (84.7M) | (122.9M) | 52.8M | (267M) | (307M) | (291.7M) | |
| Total Cash From Financing Activities | 1.1M | 438.7M | 237.3M | 33M | 38.0M | 36.1M | |
| End Period Cash Flow | 58.1M | 173.6M | 150.9M | 209M | 130M | 131.5M | |
| Other Cashflows From Investing Activities | (109.7M) | 61.1M | 3M | 51.0M | 3.5M | 3.6M | |
| Change To Netincome | 10.2M | 21.8M | 54.5M | 76M | 87.4M | 91.8M | |
| Change To Liabilities | 3.3M | 24.1M | 4.9M | (104M) | (93.6M) | (88.9M) | |
| Issuance Of Capital Stock | 1.2M | 433.8M | 220.2M | 23M | 36M | 34.2M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.